Table 1. Summary growth statistics of isolates.

Condition tested	CFUs total	Num of rep	Med td (hrs)	IQR td (hrs)	Med T-Lag time (hrs)	IQR T-Lag time (hrs)	Med T-Exp (hrs)	IQR T-Exp (hrs)	Med Num Dbl	IQR Num Dbl
Control-H37Rv	5413	8	22.9	7.8	0.0	3.7	52.5	33.8	3.1	1.6
0.0625 μg/ml-H37Rv	3380	4	23.4	9.6	0.0	2.8	51.8	28.1	3.0	1.5
0.125 µg/ml-H37Rv	2946	4	24.3	10.0	0.0	2.9	53.0	29.5	3.0	1.4
0.5 µg/ml-H37Rv	2231	4	22.6	10.7	0.9	6.2	35.2	16.2	2.0	0.9
2 µg/ml-H37Rv	5354	8	19.2	13.7	3.9	6.1	17.3	8.2	0.9	0.6
4 µg/ml-H37Rv	1412	4	21.1	12.5	3.9	5.2	14.7	7.7	0.6	0.4
8 µg/ml-H37Rv	1728	4	20.8	12.1	2.8	4.0	11.5	6.5	0.5	0.3
16 μg/ml-H37Rv	894	4	22.9	24.4	1.5	4.4	11.2	12.4	0.5	0.3
Control-TRS10	3449	8	28.4	8.5	2.8	9.3	79.7	54.2	3.5	2.5
0.0625 µg/ml-TRS10	2181	4	28.2	6.9	1.9	8.1	81.7	55.6	3.8	2.6
0.125 µg/ml-TRS10	2014	4	28.5	7.6	0.0	5.4	80.3	61.2	3.7	2.8
0.5 µg/ml-TRS10	1167	4	28.3	6.3	0.0	6.0	81.8	62.5	3.8	3.1
2 µg/ml-TRS10	2982	8	30.6	17.9	2.3	9.2	73.7	42.6	2.8	2.2
4 µg/ml-TRS10	1190	4	53.1	26.0	0.0	7.4	65.7	38.7	1.5	1.1
8 µg/ml-TRS10	1063	4	57.8	28.4	0.0	2.1	56.7	27.4	1.3	0.7
16 µg/ml-TRS10	966	4	46.0	21.8	0.0	13.8	61.8	44.8	1.6	1.3
Control-ADB42	5599	8	24.4	7.8	1.1	8.2	64.3	42.9	3.4	2.0
0.0625 µg/ml-ADB42	3762	4	24.7	7.2	0.0	5.2	63.8	35.7	3.4	1.8
0.125 µg/ml-ADB42	3980	4	25.3	7.4	0.0	4.8	63.8	35.1	3.4	1.7
0.5 µg/ml-ADB42	3121	4	25.0	9.7	0.0	6.2	40.6	31.7	2.0	1.4
2 µg/ml-ADB42	4995	8	26.9	18.0	1.9	8.0	29.5	43.3	1.1	1.7
4 µg/ml-ADB42	1440	4	36.7	27.7	5.0	13.9	38.8	51.6	0.9	1.9
8 µg/ml-ADB42	1287	4	54.7	56.2	4.1	13.2	40.0	39.2	0.6	0.9
16 µg/ml-ADB42	910	4	17.5	34.8	31.5	32.6	46.6	36.4	0.6	1.0